Related Experiment Video

Updated: Jan 18, 2026

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.7K

Mapping the cancer vaccine landscape

Fang Hu1,2, Huan Li1,3, Weiran Lv1,2

  • 1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer，Sun Yat-sen University Cancer Center, Guangzhou, China.

Journal for Immunotherapy of Cancer
|September 12, 2025
PubMed

Insights

Cancer vaccine research is rapidly advancing, with a significant increase in clinical trials, especially for therapeutic applications. These global efforts offer hope for cancer patients.

Area of Science:

  • Oncology
  • Immunology
  • Clinical Trials

Background:

  • Global cancer incidence is rising, posing significant challenges.
  • Cancer vaccines leverage the immune system to target cancer-specific features.
  • Vaccines can be classified as preventive or therapeutic.

Purpose of the Study:

  • To analyze the landscape of cancer vaccine clinical trials.
  • To identify trends in trial phases, geographic distribution, and patient populations.
  • To highlight the most studied cancer types in vaccine research.

Main Methods:

  • Searched Trialtrove database for cancer vaccine trials from January 1, 2000, to November 1, 2024.
  • Analyzed 2100 identified clinical trials.
  • Categorized trials by phase, location, age group, and cancer type.

Main Results:

  • Explosive growth in cancer vaccine trials since 2008.
  • Most trials are Phase 1 (37%) and Phase 2 (32%), with a majority in the USA (45%).
  • Non-small cell lung cancer (12%) and melanoma (11%) are the most studied types; 94% of trials focus on adults.

Conclusions:

  • Cancer vaccine research, particularly therapeutic vaccines, is rapidly advancing.
  • There is a growing number of global, multicenter clinical trials for cancer vaccines.
  • These trials show significant promise for improving outcomes for cancer patients.
Keywords:
Immune modulatoryImmunotherapyVaccine

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.4K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
976
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K